ARCHIVES

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

This article is from The Cancer Letter archive.

Vol. 29 No. 41 | November 7, 2003

Download PDF Visit The Full Archive

Related Articles

CPRU Program Gets Basic Concept Approval

October 2, 1987

Wittes, Fraumeni Appointed As Division Directors

February 9, 1996

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981

NCAB to Get NCI Bypass Budget May 13; DeVita Tells Centers That Is Where “Our Philosophy Can Be Found”

May 3, 1985

Cancer Control Awards $1 .5 Million Grant For 3-Year Study By College Of Radiology

April 26, 1974

Schmidt’s Term On Cancer Panel Expires, No Word On Reappointment

February 28, 1975